Entropy Technologies LP Takes $1.27 Million Position in Bath & Body Works, Inc. (NYSE:BBWI)

Entropy Technologies LP acquired a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 32,846 shares of the company’s stock, valued at approximately $1,273,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Golden State Wealth Management LLC acquired a new stake in shares of Bath & Body Works during the fourth quarter worth about $26,000. True Wealth Design LLC increased its stake in Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after buying an additional 1,054 shares during the period. UMB Bank n.a. lifted its holdings in Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after buying an additional 335 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its position in Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after buying an additional 900 shares during the period. Finally, Wilmington Savings Fund Society FSB acquired a new position in shares of Bath & Body Works in the third quarter worth $39,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Down 1.1 %

Shares of NYSE BBWI opened at $35.48 on Tuesday. The business has a 50-day moving average price of $37.71 and a 200 day moving average price of $33.65. The stock has a market cap of $7.68 billion, a PE ratio of 8.65, a price-to-earnings-growth ratio of 0.90 and a beta of 1.83. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.48 EPS. Sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.26 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date of this dividend is Friday, February 21st. Bath & Body Works’s dividend payout ratio is currently 19.51%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on BBWI. Barclays lifted their target price on Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a report on Tuesday, November 26th. Piper Sandler boosted their price objective on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Morgan Stanley reduced their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a report on Thursday, November 21st. JPMorgan Chase & Co. boosted their price target on shares of Bath & Body Works from $39.00 to $41.00 and gave the stock a “neutral” rating in a report on Friday, January 24th. Finally, TD Cowen raised their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, Bath & Body Works currently has an average rating of “Moderate Buy” and an average target price of $43.19.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.